CasLoc logo
All Cases PTAB Litigations UPC Oppositions

ADAPT PHARMA OPERATIONS LIMITED v. TEVA PHARMACEUTICALS USA, INC.

2:16-cv-07721

Overview

Case Number 2:16-cv-07721
Filing Date 2016-10-21
Status Terminated
Termination Date 2020-06-30
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

TEVA PHARMACEUTICALS INDUSTRIES, LTD. Operating Company

Represented By

5 Attorneys Listed

WILLIAM T. WALSH , JR

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1030

THREE GATEWAY CENTER, 100 MULBERRY STREET

HECTOR DANIEL RUIZ

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

THREE GATEWAY CENTER, 100 MULBERRY STREET

ELEONORE OFOSU-ANTWI

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

THREE GATEWAY CENTER, 100 MULBERRY STREET

LIZA M. WALSH

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

THREE GATEWAY CENTER, 100 MULBERRY STREET

MICHAEL E. PATUNAS

PATUNAS LAW LLC

Tel: +1 (973) 396-8740

24 COMMERCE STREET, SUITE 606

TEVA PHARMACEUTICALS USA, INC. Operating Company

Represented By

5 Attorneys Listed

WILLIAM T. WALSH , JR

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1030

THREE GATEWAY CENTER, 100 MULBERRY STREET

HECTOR DANIEL RUIZ

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

THREE GATEWAY CENTER, 100 MULBERRY STREET

ELEONORE OFOSU-ANTWI

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

THREE GATEWAY CENTER, 100 MULBERRY STREET

LIZA M. WALSH

WALSH PIZZI O'REILLY FALANGA LLP

Tel: +1 (973) 757-1100

THREE GATEWAY CENTER, 100 MULBERRY STREET

MICHAEL E. PATUNAS

PATUNAS LAW LLC

Tel: +1 (973) 396-8740

24 COMMERCE STREET, SUITE 606

Plaintiff

ADAPT PHARMA LIMITED NPE (University / Research)

Represented By

4 Attorneys Listed

J. BRUGH LOWER

GIBBONS PC

Tel: +1 (973) 596-4581

ONE GATEWAY CENTER, NEWARK, NJ 07102

CHARLES H. CHEVALIER

GIBBONS PC

Tel: +1 (973) 596-4500

ONE GATEWAY CENTER, NEWARK, NJ 07102

ELINA SLAVIN

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

1037 RAYMOND BOULEVARD, SUITE 1520

CHARLES MICHAEL LIZZA

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, NEWARK, NJ 07102-5490

OPIANT PHARMACEUTICALS, INC. Operating Company

Represented By

7 Attorneys Listed

J. BRUGH LOWER

GIBBONS PC

Tel: +1 (973) 596-4581

ONE GATEWAY CENTER, NEWARK, NJ 07102

CHARLES H. CHEVALIER

GIBBONS PC

Tel: +1 (973) 596-4500

ONE GATEWAY CENTER, NEWARK, NJ 07102

WILLIAM C. BATON

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.

SARAH ANN SULLIVAN

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, SUITE 1520

ELINA SLAVIN

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

1037 RAYMOND BOULEVARD, SUITE 1520

DAVID LEIGH MOSES

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6729

1037 RAYMOND BOULEVARD, SUITE 1520

CHARLES MICHAEL LIZZA

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, NEWARK, NJ 07102-5490

ADAPT PHARMA, INC. Operating Company

Represented By

8 Attorneys Listed

J. BRUGH LOWER

GIBBONS PC

Tel: +1 (973) 596-4581

ONE GATEWAY CENTER, NEWARK, NJ 07102

CHARLES H. CHEVALIER

GIBBONS PC

Tel: +1 (973) 596-4500

ONE GATEWAY CENTER, NEWARK, NJ 07102

WILLIAM C. BATON

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.

SARAH ANN SULLIVAN

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, SUITE 1520

FRANK CHARLES CALVOSA

QUINN EMANUEL UQUHART & SULLIVAL LLP

Tel: +1 (212) 849-7569

51 MADISON AVENUE, 22ND FLOOR

ELINA SLAVIN

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

1037 RAYMOND BOULEVARD, SUITE 1520

DAVID LEIGH MOSES

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6729

1037 RAYMOND BOULEVARD, SUITE 1520

CHARLES MICHAEL LIZZA

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, NEWARK, NJ 07102-5490

ADAPT PHARMA OPERATIONS LIMITED NPE (University / Research)

Represented By

8 Attorneys Listed

J. BRUGH LOWER

GIBBONS PC

Tel: +1 (973) 596-4581

ONE GATEWAY CENTER, NEWARK, NJ 07102

CHARLES H. CHEVALIER

GIBBONS PC

Tel: +1 (973) 596-4500

ONE GATEWAY CENTER, NEWARK, NJ 07102

WILLIAM C. BATON

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, 1037 RAYMOND BLVD.

SARAH ANN SULLIVAN

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, SUITE 1520

FRANK CHARLES CALVOSA

QUINN EMANUEL UQUHART & SULLIVAL LLP

Tel: +1 (212) 849-7569

51 MADISON AVENUE, 22ND FLOOR

ELINA SLAVIN

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

1037 RAYMOND BOULEVARD, SUITE 1520

DAVID LEIGH MOSES

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6729

1037 RAYMOND BOULEVARD, SUITE 1520

CHARLES MICHAEL LIZZA

SAUL EWING ARNSTEIN & LEHR LLP

Tel: +1 (973) 286-6700

ONE RIVERFRONT PLAZA, NEWARK, NJ 07102-5490

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 9 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials 10 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (9): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (10 found):
PTAB: 10
USPTO PTAB Trial 2019-02-19
IPR2019-00699

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9775838)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00698

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9775838)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00697

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9775838)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00693

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9561177)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00692

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9561177)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00691

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9561177)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00690

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9468747)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00689

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9468747)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00688

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9468747)
Status: Final Written Decision
USPTO PTAB Trial 2019-02-19
IPR2019-00687

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9775838
Nasal drug products and methods of their use
Filed: 2017-05-08
Issued: 2017-10-03
Active (10.5 yrs remaining)
Expires: 2037-05-08
US9211253
Nasal drug products and methods of their use
Filed: 2015-03-16
Issued: 2015-12-15
Active (8.3 yrs remaining)
Expires: 2035-03-16

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

15

Dispositive

0

Granted

1

Denied

0

Pending / Review

14

Motions by Category

Procedural / Extension Motion 4 Claim Construction / Markman Filing 11

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
ORDER, granting 233 Joint letter request from the parties for an extension of time to file redactions and leave to file joint omnibus motion to seal; etc. Signe...
Entry #238 • 2019-07-24 Document →
Procedural / Extension Motion Pending / Under Review
Letter from Liza M. Walsh to the Hon. Joseph A. Dickson, U.S.M.J. requesting an extension of time to file redactions and leave to file joint omnibus motion to s...
Entry #233 • 2019-07-22 Document →
Claim Construction / Markman Filing Pending / Under Review
Minute Entry for proceedings held before Chief Judge Jose L. Linares: Markman Hearing held on 3/13/2019. Court RESERVED decision. (Court Reporter/Recorder PHYLL...
Entry #188 • 2019-03-13 Document →
Claim Construction / Markman Filing Pending / Under Review
TEXT ORDER: The Court is in receipt of Plaintiffs' letter dated March 6, 2019, (ECF No.186). Pursuant to the Court's conversation with the parties at the Februa...
Entry #187 • 2019-03-07 Document →
Claim Construction / Markman Filing Pending / Under Review
TEXT ORDER: The Court is in receipt of Defendants' letter dated March 5, 2019, (ECF No.184). Pursuant to the Court's conversation with the parties at the Februa...
Entry #185 • 2019-03-06 Document →
Claim Construction / Markman Filing Pending / Under Review
Letter from Liza M. Walsh to the Hon. Jose L. Linares, Chief Judge re: Markman hearing. (WALSH, LIZA) (Entered: 03/05/2019)
Entry #184 • 2019-03-05 Document →

Docket Entries

(281 total)
Pleading / Complaint

COMPLAINT against TEVA PHARMACEUTICALS INDUSTRIES, LTD., TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 400 receipt number 0312-7434816) with JURY DEMAND, filed by ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC., ADAPT PHARMA, INC.. (Attachments: # 1 Civil Cover Sheet)(Miller, S) (Entered: 10/24/2016)

Entry #1 • 2016-10-21
1
Pleading / Complaint

COMPLAINT against TEVA PHARMACEUTICALS INDUSTRIES, LTD., TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 400 receipt number 0312-7434816) with JURY DEMAND, filed by ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC., ADAPT PHARMA, INC.. (Attachments: # 1 Civil Cover Sheet)(Miller, S) (Entered: 10/24/2016)

Entry #1 • 2016-10-21
2

Corporate Disclosure Statement by ADAPT PHARMA, INC., ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC.. (Miller, S) (Entered: 10/24/2016)

Entry #2 • 2016-10-21
1
Pleading / Complaint

AO120 Patent/Trademark Form filed. (Attachments: # 1 Complaint) (Miller, S) (Entered: 10/24/2016)

Entry #3 • 2016-10-21
1

NOTICE of Appearance by WILLIAM C. BATON on behalf of ADAMPT PHARMA, INC., ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC. (BATON, WILLIAM) (Entered: 10/24/2016)

Entry #4 • 2016-10-24
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc